In March 2025, the company declared new strategies for the direct-to-customer presenting of its Wegovy weight loss drug. The company set up a completely new pharmacy, termed NovoCare, which would charge prospects $499 per month for use of the drug, under 50 % the cost of the drug by way of other pharmaceutical distribution networks.[53]This led Nov